Tolerable Tests
Regulating Diagnostic Innovation in a Global Health Emergency, Lessons from Ebola
Bibliographic Data
| ID | 5338310 |
|---|---|
| Authors | A Street (0000-0001-7874-0234, School of Social and Political Science, The University of Edinburgh, United Kingdom, corresponding author), Ann H Kelly (0000-0003-4658-2133, King's College London) |
| Year | 2025 |
| Volume | 50 |
| Issue | 4 |
| Pages | 744-771 |
| Publication date | 2025-07-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science Technology & Human Values (JOURNAL) |
| Journal identifiers | ISSN: 0162-2439 • E-ISSN: 1552-8251 |
| Publisher | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/01622439241252709 |
| OpenAlex | W4398139721 |
| Language | EN |
| Citations received | 3 |
| References cited | 51 |
The response to the 2014-2016 West African epidemic was a watershed for emergency research and innovation, forcing a shift in regulatory norms as evidentiary standards were pitted against humanitarian imperatives and biosecurity concerns. This article examines how those ethical and epistemic negotiations unfolded in practice through the development, testing, and use of novel tools for Ebola diagnosis with a focus on Sierra Leone. We track the priorities placed on the accuracy, feasibility, and clinical efficiency of Ebola diagnostic platforms and explore how these varied over the course of the outbreak and for different actors involved in their deployment. The lack of clarity over which tools might be fit for purpose exposed the profound ambiguities around the nature, scope, and purpose of building in-country Ebola diagnostic capacity. Ultimately, we argue that the accelerated regulatory process coordinated by the World Health Organization operated as a liminal procedure that both revealed the scientific, ethical, and political trade-offs and inequalities attendant to an emerging regime of emergency research and development, and provided a tentative, reflexive platform for regulatory experimentation, deliberation, and reform
Ebola virus · Environmental health · Environmental planning · Global health · Medical emergency · Outbreak · Pathology · Public health · Biomedical Ethics and Regulation · Environmental Science · Ethics in Clinical Research · Medicine · Viral Infections and Outbreaks Research · Virology
The fifth branch
Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola
Faking global health
Comparison of social resistance to Ebola response in Sierra Leone and Guinea suggests explanations lie in political configurations not culture
Drug Evaluation and the Permissive Principle
Constructing `Do-able' Problems in Cancer Research
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
Imperfect diagnosis
The race for Ebola drugs
Expertise, Regulatory Science and the Evaluation of Technology and Risk
Science for the post-normal age
In the wake
Scientific Imaginaries and Ethical Plateaus in Contemporary U.S. Toxicology
Acting in an uncertain world
The Neoliberal Regulatory State, Industry Interests, and the Ideological Penetration of Scientific Knowledge
Introducing malaria rapid diagnostic tests at registered drug shops in Uganda
Multidisciplinary perspectives on the regulation of diagnostic technologies
Framing utility
Situating Technoscience
Post-pandemic Transformations and the Recasting of Development
Infrastructural Instability, Value, and Laboratory Work in a Public Hospital in Sierra Leone
Emerging Disease or Emerging Diagnosis
Chimeric globalism
The pragmatism of continual failure
Black' and 'white' death
On the will to ignorance in bureaucracy
| Unique citing works | 3 |
|---|---|
| Citations per year | 3 |
| Citation span | 2025 - 2026 (2) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |